Clinical Researcher—December 2019 (Volume 33, Issue 10) PI CORNER Elizabeth Weeks-Rowe, LVN, CCRA In the ever-shifting environment of priorities and processes in today’s complex clinical research landscape, one constant […]
The U.S. Food and Drug Administration (FDA) just launched CURE ID, an internet-based repository that will allow the clinical community to report experiences treating difficult-to-treat infectious diseases with novel uses […]
Drug developers and global regulators are rapidly expanding the use of real-world evidence (RWE) to design, test, and review rare disease treatments, but knowledge gaps on the part of payers […]
To the uninitiated, the term “advanced analytics” might sound a bit dry, but it holds exciting promise to make clinical trials far more efficient and deliver vital drugs and treatments […]
A new guidance from the U.S. Food and Drug Administration (FDA) offers the agency’s latest thinking on how industry should design, run, and handle data reporting when leveraging adaptive clinical […]